Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus

Annals of the New York Academy of Sciences

Volumn 1203, Issue , 2010, Pages 101-106

  Stabler, Thomas ^a   Kenjale, Aarti ^a   Ham, Katherine ^a   Jelesoff, Nicole ^a   Allen, Jason ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

diabetes mellitus; nitric oxide; vascular

Indexed keywords

NITRIC OXIDE;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; EXERCISE; HUMAN; NONHUMAN; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 77956236552     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05599.x     Document Type: Conference Paper

References (38)

1. Leahy, J.L. 2005. Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 36 : 197 209.
2. SEARCH for Diabetes in Youth Study Group. 2006. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth study. Pediatrics 118 : 1510 1518.
3. Weigensberg, M.J. M.I. Goran. 2009. Type 2 diabetes in children and adolescents. Lancet 373 : 1743 1744.
4. Beckman, J.A., M.A. Creager P. Libby. 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 : 2570 2581.
5. Haffner, S.M., S. Lehto, T. Ronnemaa, et al. 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 : 229 234.
6. Thomas, R.J., P.J. Palumbo, L.J. Melton III., et al. 2003. Trends in the mortality burden associated with diabetes mellitus: a population-based study in rochester, minn, 1970-1994. Arch. Intern. Med. 163 : 445 451.
7. Calver, A., J. Collier P. Vallance. 1992. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90 : 2548 2554.
8. Cohen, R.A. 1993. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (Suppl V V67 V76.
9. Aboyans, V., M. Criqui, J. Denenberg, et al. 2006. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 : 2623 2629.
10. Liao, J.C., T. W. Hein, M.W. Vaughn, et al. 1999. Intravascular flow decreases erythrocyte consumption of nitric oxide. PNAS 1999 96 : 8757 8761.
11. Stamler, J.S., L. Jia, J.P. Eu, et al. 1997. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276 : 2034 2037.
12. Cannon, R.O., III., A.N. Schechter, J.A. Panza, et al. 2001. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J. Clin. Invest. 108 : 279 287.
13. Rassaf, T., M. Preik, P. Kleinbongard, et al. 2002. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J. Clin. Invest. 109 : 1241 1248.
14. Schechter, A.N. M.T. Gladwin. 2003. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N. Engl. J. Med. 348 : 1483 1485.
15. The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators, CAFE Steering Committee and Writing Committee Williams, B., P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, D. Collier, A.D. Hughes, H. Thurston M. O'Rourke. 2006. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal Results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation 113 : 1213 1225.
16. Stamler, J., O. Jaraki, J. Osborne, et al. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. PNAS 89 : 7674 7677.
17. Rassaf, T, N.S. Bryan, M. Kelm M. Feelisch. 2002. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic. Biol. Med. 33 : 1590 1596.
18. Dejam, A., C.J. Hunter, A.N. Schechter M.T. Gladwin. 2004. Emerging role of nitrite in human biology. In Blood Cells, Molecules, and Diseases, Proceedings of The Red Cell Club, October 2003. 32 : 423 429.
19. Lundberg, J.O., E. Weitzberg. 2005. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 25 : 915 922.
20. Baker, P.R.S., F.J. Schopfer, S. Sweeney B.A. Freeman. 2004. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. PNAS August 10, 2004 101 : 11577 11582.
21. McMahon, T.J., R.E. Moon, B.P. Luschinger, et al. 2002. Nitric oxide in the human respiratory cycle. Nat. Med. 8 : 711 717.
22. Tesfamariam, B., M.L. Brown R.A. Cohen. 1991. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87 : 1643 1648.
23. Williams, S.B., A.B. Goldfine, F.K. Timimi, et al. 1998. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 : 1695 1701.
24. Tan, K.C.B., W.-S. Chow, V.H.G. Ai, et al. 2002. Advanced glycation end products and endothelial dysfunction in type 2 diabetes Diabetes Care 25 : 1055 1059.
25. Beckman, J.A., A.B. Goldfine, M.B. Gordon M.A. Creager. 2001. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103 : 1618 1623.
26. McMahon, T.J., G.S. Ahearn, M.P. Moya, et al. 2005. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. PNAS 102 : 14801 14806.
27. Pawloski, J.R., D.T. Hess J.S. Stamler. 2005. Impaired vasodilation by red blood cells in sickle cell disease. PNAS 102 : 2531 2536.
28. Gow, A.J. 2005. Nitric oxide, hemoglobin, and Hypoxic vasodilation. Am. J. Respir. Cell Mol. Biol. 32 : 479 482.
29. Milsom, A.B., C. Jon, J. Goodfellow, et al. 2002. Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus. Diabetologia 45 : 1515 1522.
30. James, P.E., D. Lang, T. Tufnell-Barret, et al. 2004. Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res. 94 : 976 983.
31. Bunn, H.F. R.W. Briehl. 1970. The interaction of 2,3-diphosphoglycerate with various human hemoglobins. J. Clin. Invest. 49 : 1088 1095.
32. McMahon, T.J., A. Exton Stone, J. Bonaventura, et al. 2000. Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. J. Biol. Chem. 275 : 16738 16745.
33. Gonzalez-Alonso, J., S.P. Mortensen, E.A. Dawson, et al. 2006. Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of haemoglobin. J. Physiol. 572 : 295 305.
34. Roach, R.C., M.D. Koskolou, J.A.L. Calbet B. Saltin. 1999. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am. J. Physiol. Heart Circ. Physiol. 276 : H438 H445.
35. Pinder, A., E. Pittaway, K. Morris P. James. 2009. Nitrite directly vasodilates hypoxic vasculature via nitric oxide dependent and independent pathways. Br. J. Pharmacol. 158 : 1523 1530.
36. Lundberg, J.O., E. Weitzberg M.T. Gladwin. 2008. The nitrate-nitrite- nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7 : 156 167.
37. Allen, J., E. Miller, E. Schwark, et al. 2009. Plasma nitrite response and arterial reactivity differentiate cardiovascular health status and performance. Nitric Oxide Biol. Chem. 20 : 231 237.
38. Gow, A.J. J.S. Stamler. 1998. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391 : 169 173.